Inventor · disambiguated record
Christophe Bonny
Also filed as: BONNY CHRISTOPHE
31 granted patents·22 pending applications·569 citations·filing 1997–2024
97Inventor score
Top patents by PatentIndex Score
53 records- 0198US6960648B2Intracellular delivery of biological effectorsUNIV LAUSANNE·Filed 2001·Granted Nov 1, 2005·142 cites·4 claims
- 0296US8278413B2Cell-permeable peptide inhibitors of the JNK signal transduction pathwayBONNY CHRISTOPHE·Filed 2011·Granted Oct 2, 2012·23 cites·7 claims
- 0395US10023615B2Efficient transport into white blood cellsBONNY CHRISTOPHE·Filed 2009·Granted Jul 17, 2018·33 cites·11 claims
- 0495US6610820B1Cell-permeable peptide inhibitors of the JNK signal transduction pathwayUNIV LAUSANNE·Filed 2000·Granted Aug 26, 2003·63 cites·20 claims
- 0593US8236924B2Cell-permeable peptide inhibitors of the JNK signal transduction pathwayBONNY CHRISTOPHE·Filed 2008·Granted Aug 7, 2012·19 cites·21 claims
- 0692US8080517B2Cell-permeable peptide inhibitors of the JNK signal transduction pathwayBONNY CHRISTOPHE·Filed 2005·Granted Dec 20, 2011·17 cites·6 claims
- 0792US7034109B2Intracellular delivery of biological effectorsBONNY CHRISTOPHE·Filed 2001·Granted Apr 25, 2006·36 cites·14 claims
- 0891US10131690B2C6S specific transporter moleculesPHI PHARMA SA·Filed 2015·Granted Nov 20, 2018·13 cites·20 claims
- 0991US9180159B2Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseasesBONNY CHRISTOPHE·Filed 2009·Granted Nov 10, 2015·8 cites·11 claims
- 1091US8981052B2JNK inhibitor moleculesBONNY CHRISTOPHE·Filed 2011·Granted Mar 17, 2015·9 cites·15 claims
- 1191US8748395B2Cell-permeable peptide inhibitors of the JNK signal transduction pathwayBONNY CHRISTOPHE·Filed 2006·Granted Jun 10, 2014·11 cites·21 claims
- 1291US7943574B2Cell-permeable peptide inhibitors of the JNK signal transduction pathwayXIGEN SA·Filed 2009·Granted May 17, 2011·15 cites·4 claims
- 1391US6780970B2Cell-permeable peptide inhibitors of the JNK signal transduction pathwayUNIV LAUSANNE·Filed 2001·Granted Aug 24, 2004·29 cites·13 claims
- 1490US9624267B2JNK inhibitor moleculesXIGEN INFLAMMATION LTD·Filed 2015·Granted Apr 18, 2017·5 cites·11 claims
- 1589US8569447B2Cell-permeable peptide inhibitors of the JNK signal transduction pathwayBONNY CHRISTOPHE·Filed 2012·Granted Oct 29, 2013·9 cites·5 claims
- 1689US8183339B1Cell-permeable peptide inhibitors of the JNK signal transduction pathwayBONNY CHRISTOPHE·Filed 2000·Granted May 22, 2012·15 cites·7 claims
- 1789US7635681B2Cell-permeable peptide inhibitors of the JNK signal transduction pathwayXIGEN SA·Filed 2003·Granted Dec 22, 2009·28 cites·3 claims
- 1888US7538091B2Intracellular delivery of biological effectorsXIGEN SA·Filed 2006·Granted May 26, 2009·9 cites·14 claims
- 1986US9610330B2Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseasesXIGEN INFLAMMATION LTD·Filed 2015·Granted Apr 4, 2017·5 cites·14 claims
- 2086US9006185B2Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseasesBONNY CHRISTOPHE·Filed 2009·Granted Apr 14, 2015·7 cites·16 claims
- 2185US9290538B2Cell-permeable peptide inhibitors of the JNK signal transduction pathwayXIGEN INFLAMMATION LTD·Filed 2013·Granted Mar 22, 2016·5 cites·18 claims
- 2282US5880261ATranscription factor Islet-Brain 1 (IB1)Filed 1997·Granted Mar 9, 1999·47 cites·4 claims
- 2379US12016910B2Antigenic peptides for prevention and treatment of cancerENTEROME S A·Filed 2019·Granted Jun 25, 2024·1 cites·30 claims
- 2477US12364743B2Microbiota sequence variants of tumor-related antigenic epitopesENTEROME S A·Filed 2023·Granted Jul 22, 2025·0 cites·14 claims
- 2575US7803749B2Peptide inhibitors of MKK7 kinase binding to insulin binding proteinsXIGEN SA·Filed 2003·Granted Sep 28, 2010·6 cites·7 claims
- 2675US2024293520A1Antigenic Peptides For Prevention And Treatment Of CancerENTEROME S A·Filed 2024·Application pending·0 cites
- 2774US11712465B2Microbiota sequence variants of tumor-related antigenic epitopesENTEROME S A·Filed 2017·Granted Aug 1, 2023·1 cites·12 claims
- 2874US7033597B2Intracellular delivery of biological effectorsUNIV LAUSANNE·Filed 2002·Granted Apr 25, 2006·5 cites·13 claims
- 2966US9688723B2C4S proteoglycan specific transporter moleculesPHI PHARMA SA·Filed 2013·Granted Jun 27, 2017·1 cites·22 claims
- 3066US2020062805A1Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction PathwayXIGEN INFLAMMATION LTD·Filed 2019·Application pending·0 cites
- 3160US2017320917A1Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction PathwayXIGEN INFLAMMATION LTD·Filed 2017·Application pending·0 cites
- 3260US2005043241A1Cell-permeable peptide inhibitors of the JNK signal transduction pathwayFiled 2004·Application pending·0 cites
- 3360US2012148590A1Cell-permeable peptide inhibitors of the jnk signal transduction pathwayBONNY CHRISTOPHE·Filed 2011·Application pending·0 cites
- 3459US2014057834A1Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction PathwayXIGEN SA·Filed 2013·Application pending·0 cites
- 3556US2016264630A1Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction PathwayXIGEN INFLAMMATION LTD·Filed 2016·Application pending·0 cites
- 3655US2003220480A1Cell-permeable peptide inhibitors of the JNK signal transduction pathwayFiled 2003·Application pending·0 cites
- 3755US2004082509A1Cell-permeable peptide inhibitors of the JNK signal transduction pathwayFiled 2003·Application pending·0 cites
- 3855US2024327471A1Il-10 inducing polypeptides and uses thereofENTEROME S A·Filed 2022·Application pending·0 cites
- 3953US2010216716A1Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction PathwayBONNY CHRISTOPHE·Filed 2010·Application pending·0 cites
- 4053US2010256041A1Conjugate Molecule Compounds With Enhanced Cell Uptake ActivityBONNY CHRISTOPHE·Filed 2009·Application pending·0 cites
- 4152US2019337988A1Novel transporter constructs and transporter cargo conjugate moleculesXIGEN INFLAMMATION LTD·Filed 2018·Application pending·0 cites
- 4252US2006178310A1Intracellular delivery of biological effectorsBONNY CHRISTOPHE·Filed 2006·Application pending·0 cites
- 4351US2023221331A1Identification And Synthesis Of Drug Candidates Derived From Human Microbiome Metasecretome ProteinsENTEROME S A·Filed 2021·Application pending·0 cites
- 4451US2021207127A1Ligands and methods of selecting binding targets for suchBICYCLERD·Filed 2019·Application pending·0 cites
- 4549US6620914B1Transcription factor islet-brain 1 (IB1)WAEBER GERARD·Filed 1998·Granted Sep 16, 2003·7 cites·10 claims
- 4648US2023068615A1Microbiota-Derived Proteins Inducing Il-10 Release From Human Cells And Uses ThereofENTEROME S A·Filed 2021·Application pending·0 cites
- 4747US11898210B2Tools for assessing FimH blockers therapeutic efficiencyENTEROME·Filed 2018·Granted Feb 13, 2024·0 cites·8 claims
- 4847US2023257423A1Compositions for treating epithelial barrier function disordersENTEROME·Filed 2021·Application pending·0 cites
- 4945US2021106652A1Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And InflammationENTEROME S A·Filed 2019·Application pending·0 cites
- 5043US2008274956A1Fusion Protein Comprising a Bh3-Domain of a Bh3-Only ProteinXIGEN SA·Filed 2005·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Christophe Bonny files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →